Popular on EntSun
- 420 Enthusiasts Prepare to Celebrate Adult Use with Outdoor Shopping and Music Festival ft Hip-Hop group the Luniz - 143
- Fred's Internet Island Is Your Virtual Oasis In Cyberspace. Feel Free To Surf Yourself Silly - 141
- Syed Shah - Mr. Pakistan World 2021 - 108
- Memories About Early Lee County to Highlight 2021 Cracker Dinner
- FuseFX Acquires Australia-based Rising Sun Pictures
- Rock and Roll San Diego Acquires Event Equipment Rental Company Spectrum Audio To Increase Event Product Availability
- WIZARD WORLD™ Issues Call to Action to Its Fanbase
- StageIt.com Showing - Meet the Author - Script Talk
- Charles Arnell joins Fast Mobile Home Loans
- Registration now open for 2021 NATP National Conference
Similar on EntSun
- Build remote and flexible Supply Chain solutions with Stockarea
- Inframark Acquires Environmental Development Partners
- Womxn of Color Summit's The Art of Authentic Living Brought Over 350 Women of Color and Non-Binary People of Color Together to Heal in Community
- National Association of Tax Professionals announces sessions in virtual education event
- HomeCentris Healthcare Announces Expansion into Pennsylvania
- B Martin Launches "Purpose Driven Artists" Record Label To Create Songs That Heal
- Parvati Foundation Leads Arctic Free To Save The World
- hellowater®, the Water That Works™ brand launches hellowater Defense power by CYTO+
- PocketSuite Partners With ShearShare to Help Stylists Boost Business
- PEI Selected Three-Time Top Microsoft Gold Partner in the U.S
Braeden Lichti: Healthcare Investing in 2021
EntSun News/10862849
VANCOUVER, British Columbia - EntSun -- Tech and healthcare are working together in the COVID-19 pandemic to benefit the greater good. That's why CNBC has predicted that both industries, including biopharma and biotech, will make gains in 2021. COVID-19 has put biopharma in the limelight and big-name tech investors are moving in: for example, tech entrepreneur and Facebook co-founder Peter Thiel recently joined a $35.4 million Series B round for Peptilogics.
Biopharma has made strides in 2020 and is on track for even more milestones in 2021. Big data and machine learning have helped biopharma better understand biological systems and diseases, and have enabled drug discovery, and pre-clinical testing. Such high-tech tools have helped accelerate the pace of innovation by being able to perform high-throughput virtual testing of large databases of molecules to find treatments.
More on EntSun News
During the COVID-19 pandemic, biopharma has persevered and collaborated at record speed to adapt and incorporate new technologies that can expedite innovation to find treatments and vaccines for the novel coronavirus. The industry has relied heavily on artificial intelligence (AI) and big data to help with the real-time development of vaccines. For example, the Moderna COVID-19 vaccine took 42 days to develop, from mRNA sequence selection to clinical testing, due to the use of computer modeling to help determine what part of the novel coronavirus's spike protein would be best equipped to be used in the vaccine. Similarly, Eli Lilly used AbCellera's AI-driven therapeutic antibody drug discovery platform to identify relevant antibodies needed for the treatment in a period of just three months.
In 2020, software technology helped reduce the high amount of risk inherent in the pharma industry. By using AI for mRNA sequence selection, Moderna saved itself the trouble of years of pre-clinical research, as can be standard in drug development and discovery. What's more, by using computer modelling to identify compounds for therapeutics, this has saved time and failures later on down the line that could occur after a decade or more of clinical trials testing.
More on EntSun News
Now that we have proven a way to reduce the risk of clinical failures and could potentially speed up drug development in multiple areas of unmet need, the biopharma sector is becoming a more attractive asset class. Machines can help us find drugs that would be normally researched by scientists in labs for years, perhaps even decades, with a high risk of failure once the drug of interest got to clinical trials. Other drugs being worked on in non-COVID-19-related therapeutics use machine learning that helps pick compounds as well. Now that Moderna has found success with the mRNA-1273 vaccine for COVID-19, they are launching new vaccines, including an HIV mRNA vaccine.
Biopharma, despite the inherent risk, is also seen as recession-proof — "the demand for life-saving medications is not going to change," regardless of the time, as Patti Seymour of BDO states. Furthermore, even in economically tough times, healthcare expenditure has stayed the same or increased. Currently, we are at all-time market highs and can expect a pullback or dip. Healthcare innovation is a necessity, though, especially in a pandemic — biopharma is a place to invest for the long term.
Healthcare presents an attractive opportunity, with biotech, medical devices, and medical services, to shine. With significant opportunities to capture above-market gains and beat the market, healthcare may prove a lucrative investment this year.
Biopharma has made strides in 2020 and is on track for even more milestones in 2021. Big data and machine learning have helped biopharma better understand biological systems and diseases, and have enabled drug discovery, and pre-clinical testing. Such high-tech tools have helped accelerate the pace of innovation by being able to perform high-throughput virtual testing of large databases of molecules to find treatments.
More on EntSun News
- Truck Jewelry Art Series Launches April 30th in Harlem
- Inframark Acquires Environmental Development Partners
- 150+ Actors and Talent in the Philadelphia Region come together for 12-Short Film Project, releasing
- Amazon Prime TOP 5 Hit Movie Secret Society is doing Amazing
- ResortNet Completes Installation Of Fiber-To-The-Home (FTTH) to Rural Colorado Residential Community
During the COVID-19 pandemic, biopharma has persevered and collaborated at record speed to adapt and incorporate new technologies that can expedite innovation to find treatments and vaccines for the novel coronavirus. The industry has relied heavily on artificial intelligence (AI) and big data to help with the real-time development of vaccines. For example, the Moderna COVID-19 vaccine took 42 days to develop, from mRNA sequence selection to clinical testing, due to the use of computer modeling to help determine what part of the novel coronavirus's spike protein would be best equipped to be used in the vaccine. Similarly, Eli Lilly used AbCellera's AI-driven therapeutic antibody drug discovery platform to identify relevant antibodies needed for the treatment in a period of just three months.
In 2020, software technology helped reduce the high amount of risk inherent in the pharma industry. By using AI for mRNA sequence selection, Moderna saved itself the trouble of years of pre-clinical research, as can be standard in drug development and discovery. What's more, by using computer modelling to identify compounds for therapeutics, this has saved time and failures later on down the line that could occur after a decade or more of clinical trials testing.
More on EntSun News
- Womxn of Color Summit's The Art of Authentic Living Brought Over 350 Women of Color and Non-Binary People of Color Together to Heal in Community
- A Timeless $14 Million, Mediterranean Villa is one of the Highest-Priced Listings In Tampa
- National Association of Tax Professionals announces sessions in virtual education event
- Doc Holidae drops new single MY WAY
- Annapolis Shakespeare Company Presents UNIFIED JAZZ ENSEMBLE featuring Bruce Swaim
Now that we have proven a way to reduce the risk of clinical failures and could potentially speed up drug development in multiple areas of unmet need, the biopharma sector is becoming a more attractive asset class. Machines can help us find drugs that would be normally researched by scientists in labs for years, perhaps even decades, with a high risk of failure once the drug of interest got to clinical trials. Other drugs being worked on in non-COVID-19-related therapeutics use machine learning that helps pick compounds as well. Now that Moderna has found success with the mRNA-1273 vaccine for COVID-19, they are launching new vaccines, including an HIV mRNA vaccine.
Biopharma, despite the inherent risk, is also seen as recession-proof — "the demand for life-saving medications is not going to change," regardless of the time, as Patti Seymour of BDO states. Furthermore, even in economically tough times, healthcare expenditure has stayed the same or increased. Currently, we are at all-time market highs and can expect a pullback or dip. Healthcare innovation is a necessity, though, especially in a pandemic — biopharma is a place to invest for the long term.
Healthcare presents an attractive opportunity, with biotech, medical devices, and medical services, to shine. With significant opportunities to capture above-market gains and beat the market, healthcare may prove a lucrative investment this year.
Source: Braeden Lichti
Filed Under: Business
0 Comments
Latest on EntSun News
- hellowater®, the Water That Works™ brand launches hellowater Defense power by CYTO+
- Celebrate Golden Week in Tokyo with 1,000 Colorful Carp Streamers
- Viva Tequila Festival Mexico Experience Tour Honored at Taste Awards in the Outstanding Culinary & Travel Experience Category
- BGE Digital Distribution Announces Client Producer 9-0 Receiving Verified Account on Soundcloud
- Singer, Songwriter, Pianist, Isabel Marcheselli Garners Generous Grant Support
- ICYS ACCESSORIES Black Woman Owned and Minority Supported
- International Fine and Decorative Art Auction April 24-25
- #1 Billboard Jazz Artist Ski Johnson to Release 10th Studio Album and Tell All Movie
- PocketSuite Partners With ShearShare to Help Stylists Boost Business
- Isaac of "The Love Boat" Mother Jerri Lange, Bay Area Media Legend, Social Activist Has Passed
- The Anderson Group Real Estate Services' New Concierge Program Aims To Help Nashville-area Homeowners Sell For Top Dollar
- Country Singer Songwriter Hollyann Unveils New Single "And Then"
- West Coast Customs icon launches "CarCoin" NFT, giving away an original WCC designed vehicle to celebrate
- Travel Nurse Meisha Amia Announces Launch of New Vegan Leather Bag, titled The CEO Tote
- PEI Selected Three-Time Top Microsoft Gold Partner in the U.S
- Daisy Daniels, is a young emerging artist from Italy. Launching her fresh new single "Insane"
- Event Honors Excellence in Songwriting - Great American Song Contest Winners Announced
- New Book "Educating Marston" Provides Hope for Anyone Struggling to Find Answers Raising a Child with Autism
- The Miguel Wilson Collection celebrates the grand opening of its New York City location
- Terri Ross, Renowned Practice Consultant, Joins Dozens of Industry Thought Leaders to Speak at the ISAPS Business School Program